<DOC>
	<DOCNO>NCT01335451</DOCNO>
	<brief_summary>The purpose study investigate safety , tolerability pharmacokinetics AZD5213 healthy young elderly Japanese subject</brief_summary>
	<brief_title>Assess Safety , Tolerability Pharmacokinetics AZD5213 After Single Multiple Ascending Oral Doses Healthy Young Elderly Japanese Subjects</brief_title>
	<detailed_description />
	<criteria>Provision sign date , write informed consent prior study specific procedures Japanese healthy male subject age 20 45 year ( young ) male female subject age 65 80 year ( elderly ) Male subject willing use barrier contraception ie , condom , first day dose 3 month last dose investigational product Have body mass index ( BMI ) 17 27 kg/m2 weigh least 45 kg 100 kg Clinically normal physical finding , supine BP , pulse rate , ECG laboratory assessment relation age , judge investigator ( ) History clinically significant disease disorder , opinion investigator , may either put subject risk participation study , influence result subject 's ability participate study History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug History previous ongoing psychiatric disease/condition include psychosis , affective disorder , anxiety disorder , personality disorder include borderline accord criterion Diagnostic Statistical Manual Mental Disorders History psychotic disorder among first degree relative . History use antipsychotic , antidepressant anxiolytic drug , prescribe well nonprescribed use .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>AZD5213</keyword>
	<keyword>safety</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>single dose</keyword>
	<keyword>repeat dose</keyword>
	<keyword>young</keyword>
	<keyword>elderly</keyword>
	<keyword>Japanese</keyword>
	<keyword>healthy subject</keyword>
</DOC>